2023年报业绩点评:现金流大幅改善,海外表现亮眼
CHUNLI MEDICAL(688236) 国泰君安·2024-03-31 16:00
| --- | --- | --- | |----------|-------------------|-----------------------| | | | | | | 丁丹 ( 分析师 ) | 谈嘉程 ( 分析师 ) | | | 0755-23976735 | 021-38038429 | | | dingdan@gtjas.com | tanjiacheng@gtjas.com | | 证书编号 | S0880514030001 | S0880523070004 | 16% 春立医疗 上证指数 | --- | --- | --- | --- | |------------------------------------------------------------|----------------|------------------|---------------| | | | | | | 3% -10% | | | | | -24% | | | | | -37% | | | | | -51% 2023-03 2023-06 | 2023-09 | 2023-12 | 2024-03 | | ...